Quoi de NeuF

Get all the news on neurofibromatosis every month! Here is the May 2021 issue.

Quoi de NeuF – May 2021 (French only)

Download PDF

Here’s what’s in store for you this month in Quoi de NeuF:

  • State of the art on animal models of NFs, a crucial step before clinical studies
  • Technical feat: an organoid model of neurofibromas made from the skin and tumours of NF1 patients
  • NF2: discoveries leading to new therapeutic targets
  • Koselugo: The first drug for NF1 is approved in Europe